Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Renaparin by Corline Biomedical for Delayed Graft Function (DGF): Likelihood of Approval
Renaparin is under clinical development by Corline Biomedical and currently in Phase I for Delayed Graft Function (DGF). According to...